Hormonal
In morbidly obese individuals, elevated tonic glucose metabolism in the dorsal caudate nucleus mediates abnormal anticipatory reward processing, characterized by heightened connectivity with the amygdala and insula and a failure to activate dorsolateral prefrontal inhibitory control when viewing appetizing food cues.
If you struggle with obesity, your brain may be biologically wired to react more strongly to food cues than others. This isn't a moral failing; it's a neurobiological reality where the 'reward' center (caudate) is overactive and the 'control' center (prefrontal cortex) is underactive. Recognizing this helps shift the strategy from 'trying harder' to 'managing cues' (e.g., removing visual food triggers) to bypass the hyperactive reward pathway.
These findings suggest that enhanced sensitivity to external food cues in obesity may involve abnormal stimulus-response learning and incentive motivation subserved by the dorsal caudate nucleus, which in turn may be due to abnormally high input from the amygdala and insula and dysfunctional inhibitory control by the frontal cortical regions.
Why this rating
High-quality multimodal imaging (PET/fMRI) with rigorous controls (hyperinsulinemic clamp), though the sample size is small (n=19 obese, n=16 controls).
Source
Dorsal Striatum and Its Limbic Connectivity Mediate Abnormal Anticipatory Reward Processing in Obesity
Lauri Nummenmaa et al. · PLoS ONE · 2012
DOI 10.1371/journal.pone.0031089
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →